Company / Tangible Book Value per Share
Matinas BioPharma Holdings, Inc. Tangible Book Value per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$1.75
FY2024
5-year range
$0.16 / $1.75
FY2020-FY2024
Trend
+975.0%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Tangible Book Value per Share changed +975% YoY in FY2024, a notable deviation from the 9-year average annual change of +122%.
Based on SEC 10-K filings.
1.75 in FY2024 with a 5-year CAGR of +68.0%.
Improved from $0.24 to $1.75 over the past 2 years.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- +89.8%
- 5-Year CAGR
- +68.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, tangible book value per share increased 975.0% year-over-year.
- Lowest tangible book value per share in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -18.50 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $1.75 | +975.0% |
| FY2023 | $0.16 | -31.3% |
| FY2022 | $0.24 | -7.5% |
| FY2021 | $0.26 | -33.2% |
| FY2020 | $0.38 | +192.6% |
| FY2019 | $0.13 | +30.6% |
| FY2018 | $0.10 | +0.1% |
| FY2017 | $0.10 | -1.7% |
| FY2016 | $0.10 | -30.7% |
| FY2015 | $0.15 | - |
As of FY2024 · SEC 10-K · Updated Jun 24, 2026